Concepts (306)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ethics, Medical | 13 | 2021 | 296 | 2.330 |
Why?
|
| Physician-Patient Relations | 17 | 2023 | 576 | 1.720 |
Why?
|
| Decision Making | 16 | 2020 | 674 | 1.510 |
Why?
|
| Physicians | 12 | 2025 | 682 | 1.380 |
Why?
|
| Ethics Consultation | 3 | 2019 | 12 | 1.210 |
Why?
|
| Bioethics | 4 | 2019 | 37 | 1.190 |
Why?
|
| Living Donors | 9 | 2014 | 347 | 1.140 |
Why?
|
| Suicide, Assisted | 2 | 2019 | 36 | 1.120 |
Why?
|
| Ethics, Clinical | 7 | 2019 | 47 | 1.060 |
Why?
|
| Proxy | 4 | 2020 | 27 | 1.060 |
Why?
|
| Patient Selection | 5 | 2020 | 690 | 0.910 |
Why?
|
| Curriculum | 3 | 2021 | 594 | 0.870 |
Why?
|
| Nasturtium | 1 | 2020 | 3 | 0.640 |
Why?
|
| Fasciola hepatica | 1 | 2020 | 4 | 0.640 |
Why?
|
| Antibodies, Helminth | 1 | 2020 | 10 | 0.640 |
Why?
|
| Fascioliasis | 1 | 2020 | 5 | 0.640 |
Why?
|
| Dyspepsia | 1 | 2020 | 9 | 0.640 |
Why?
|
| Mental Competency | 4 | 2017 | 49 | 0.620 |
Why?
|
| Decision Making, Organizational | 1 | 2019 | 5 | 0.610 |
Why?
|
| Eosinophilia | 1 | 2020 | 87 | 0.610 |
Why?
|
| Mental Health | 1 | 2020 | 188 | 0.590 |
Why?
|
| Prisoners | 1 | 2019 | 47 | 0.570 |
Why?
|
| Psychiatry | 1 | 2019 | 86 | 0.570 |
Why?
|
| Gastroenterology | 1 | 2021 | 157 | 0.560 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2019 | 64 | 0.560 |
Why?
|
| Personal Autonomy | 3 | 2018 | 120 | 0.560 |
Why?
|
| Liver Transplantation | 7 | 2013 | 1194 | 0.550 |
Why?
|
| Humans | 71 | 2025 | 93515 | 0.540 |
Why?
|
| Teaching | 5 | 2019 | 141 | 0.530 |
Why?
|
| Informed Consent | 5 | 2020 | 277 | 0.490 |
Why?
|
| Pain Management | 1 | 2018 | 180 | 0.480 |
Why?
|
| Internship and Residency | 4 | 2021 | 1090 | 0.480 |
Why?
|
| Health Services Accessibility | 2 | 2019 | 481 | 0.480 |
Why?
|
| Schools, Medical | 1 | 2017 | 131 | 0.460 |
Why?
|
| Paternalism | 2 | 2015 | 24 | 0.460 |
Why?
|
| United States | 25 | 2025 | 7622 | 0.450 |
Why?
|
| Hematologic Neoplasms | 1 | 2019 | 372 | 0.450 |
Why?
|
| Liver | 1 | 2020 | 1210 | 0.450 |
Why?
|
| Donor Selection | 2 | 2014 | 81 | 0.440 |
Why?
|
| Opioid-Related Disorders | 1 | 2018 | 233 | 0.430 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2017 | 179 | 0.420 |
Why?
|
| Physician's Role | 4 | 2016 | 176 | 0.410 |
Why?
|
| Communication | 7 | 2023 | 434 | 0.400 |
Why?
|
| Analgesics, Opioid | 1 | 2018 | 513 | 0.400 |
Why?
|
| General Surgery | 2 | 2019 | 248 | 0.380 |
Why?
|
| Social Values | 4 | 2015 | 44 | 0.370 |
Why?
|
| Health Care Rationing | 3 | 2020 | 83 | 0.360 |
Why?
|
| Tissue and Organ Procurement | 4 | 2023 | 388 | 0.360 |
Why?
|
| Referral and Consultation | 2 | 2014 | 375 | 0.350 |
Why?
|
| Medical Futility | 2 | 2020 | 34 | 0.350 |
Why?
|
| Patient Preference | 3 | 2020 | 125 | 0.320 |
Why?
|
| Kidney Transplantation | 2 | 2014 | 870 | 0.320 |
Why?
|
| Ethicists | 3 | 2019 | 20 | 0.310 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2022 | 217 | 0.310 |
Why?
|
| Liver Neoplasms | 2 | 2014 | 776 | 0.290 |
Why?
|
| Professional-Family Relations | 3 | 2020 | 55 | 0.290 |
Why?
|
| Attitude of Health Personnel | 4 | 2025 | 660 | 0.290 |
Why?
|
| Intensive Care Units | 3 | 2020 | 454 | 0.280 |
Why?
|
| Pharmaceutical Preparations | 2 | 2020 | 97 | 0.280 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2011 | 418 | 0.260 |
Why?
|
| Registries | 3 | 2020 | 990 | 0.250 |
Why?
|
| Third-Party Consent | 3 | 2020 | 24 | 0.240 |
Why?
|
| Waiting Lists | 3 | 2023 | 210 | 0.240 |
Why?
|
| Peer Review, Research | 1 | 2006 | 37 | 0.240 |
Why?
|
| Clinical Decision-Making | 2 | 2021 | 291 | 0.240 |
Why?
|
| Authorship | 1 | 2006 | 26 | 0.240 |
Why?
|
| Editorial Policies | 1 | 2006 | 33 | 0.240 |
Why?
|
| Quality Improvement | 2 | 2021 | 485 | 0.230 |
Why?
|
| Health Care Costs | 3 | 2014 | 251 | 0.230 |
Why?
|
| Therapeutic Human Experimentation | 1 | 2005 | 20 | 0.230 |
Why?
|
| Therapies, Investigational | 1 | 2005 | 17 | 0.230 |
Why?
|
| Conflict of Interest | 2 | 2014 | 70 | 0.230 |
Why?
|
| Students, Medical | 2 | 2023 | 435 | 0.220 |
Why?
|
| Climate Change | 1 | 2025 | 61 | 0.220 |
Why?
|
| Ethics, Research | 2 | 2007 | 53 | 0.220 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2005 | 52 | 0.220 |
Why?
|
| Intraoperative Complications | 1 | 2006 | 195 | 0.210 |
Why?
|
| Surgical Procedures, Operative | 3 | 2016 | 217 | 0.210 |
Why?
|
| Periodicals as Topic | 1 | 2006 | 168 | 0.210 |
Why?
|
| Cross-Sectional Studies | 8 | 2025 | 1847 | 0.210 |
Why?
|
| Drugs, Investigational | 1 | 2004 | 37 | 0.200 |
Why?
|
| Heart Transplantation | 3 | 2020 | 811 | 0.200 |
Why?
|
| Colectomy | 1 | 2005 | 192 | 0.200 |
Why?
|
| Organ Transplantation | 2 | 2023 | 295 | 0.200 |
Why?
|
| Research Subjects | 1 | 2004 | 73 | 0.200 |
Why?
|
| Research Support as Topic | 1 | 2004 | 89 | 0.200 |
Why?
|
| Drug Industry | 1 | 2004 | 56 | 0.200 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2004 | 148 | 0.200 |
Why?
|
| Information Dissemination | 1 | 2004 | 124 | 0.190 |
Why?
|
| Health Planning | 1 | 2003 | 16 | 0.190 |
Why?
|
| Female | 23 | 2025 | 48702 | 0.190 |
Why?
|
| Pharmacogenetics | 2 | 2019 | 456 | 0.190 |
Why?
|
| Longevity | 1 | 2003 | 60 | 0.190 |
Why?
|
| Pharmacists | 2 | 2020 | 36 | 0.190 |
Why?
|
| Biomedical Research | 2 | 2007 | 438 | 0.180 |
Why?
|
| Intestinal Obstruction | 1 | 2003 | 93 | 0.180 |
Why?
|
| Hepatectomy | 4 | 2014 | 177 | 0.180 |
Why?
|
| Middle Aged | 15 | 2025 | 27573 | 0.180 |
Why?
|
| Dissent and Disputes | 2 | 2015 | 28 | 0.170 |
Why?
|
| Surveys and Questionnaires | 5 | 2025 | 2802 | 0.170 |
Why?
|
| Academic Medical Centers | 3 | 2019 | 394 | 0.170 |
Why?
|
| Frailty | 1 | 2023 | 94 | 0.170 |
Why?
|
| District of Columbia | 1 | 2020 | 19 | 0.170 |
Why?
|
| Quality of Health Care | 2 | 2008 | 382 | 0.170 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2014 | 624 | 0.160 |
Why?
|
| Delivery of Health Care | 1 | 2025 | 452 | 0.160 |
Why?
|
| History, 20th Century | 2 | 2019 | 314 | 0.160 |
Why?
|
| Antiplatyhelmintic Agents | 1 | 2020 | 5 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 3 | 2020 | 1053 | 0.160 |
Why?
|
| Advance Directives | 1 | 2020 | 64 | 0.160 |
Why?
|
| Life Cycle Stages | 1 | 2020 | 16 | 0.160 |
Why?
|
| Family | 3 | 2019 | 324 | 0.160 |
Why?
|
| Ventilators, Mechanical | 1 | 2020 | 43 | 0.160 |
Why?
|
| Patient Care | 4 | 2020 | 97 | 0.150 |
Why?
|
| Surgeons | 2 | 2014 | 292 | 0.150 |
Why?
|
| Travel | 1 | 2020 | 73 | 0.150 |
Why?
|
| Emergencies | 1 | 2020 | 122 | 0.150 |
Why?
|
| Prisons | 1 | 2019 | 15 | 0.150 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2019 | 9 | 0.150 |
Why?
|
| Pharmacy | 1 | 2019 | 9 | 0.150 |
Why?
|
| Consultants | 1 | 2019 | 7 | 0.150 |
Why?
|
| Abdominal Pain | 1 | 2020 | 143 | 0.150 |
Why?
|
| Wakefulness | 1 | 2019 | 131 | 0.140 |
Why?
|
| Prescription Drugs | 1 | 2019 | 38 | 0.140 |
Why?
|
| Clinical Trials as Topic | 1 | 2004 | 1103 | 0.140 |
Why?
|
| Health Services Research | 1 | 2019 | 142 | 0.140 |
Why?
|
| Male | 21 | 2025 | 44557 | 0.140 |
Why?
|
| Certification | 1 | 2019 | 60 | 0.140 |
Why?
|
| Medical Overuse | 1 | 2018 | 30 | 0.140 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 150 | 0.130 |
Why?
|
| Chicago | 2 | 2019 | 1464 | 0.130 |
Why?
|
| Cost-Benefit Analysis | 2 | 2014 | 492 | 0.130 |
Why?
|
| State Government | 1 | 2017 | 24 | 0.130 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 423 | 0.130 |
Why?
|
| Terminal Care | 1 | 2018 | 146 | 0.120 |
Why?
|
| China | 1 | 2017 | 264 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1546 | 0.120 |
Why?
|
| Quality of Life | 2 | 2008 | 1780 | 0.110 |
Why?
|
| Intraoperative Care | 1 | 2016 | 88 | 0.110 |
Why?
|
| Incidental Findings | 1 | 2016 | 97 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 557 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 338 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 333 | 0.110 |
Why?
|
| Cultural Characteristics | 1 | 2015 | 19 | 0.110 |
Why?
|
| Negotiating | 1 | 2015 | 19 | 0.110 |
Why?
|
| Faculty, Medical | 1 | 2017 | 187 | 0.110 |
Why?
|
| Intraoperative Period | 1 | 2014 | 94 | 0.110 |
Why?
|
| Inventions | 1 | 2014 | 14 | 0.110 |
Why?
|
| Societies, Medical | 1 | 2018 | 621 | 0.100 |
Why?
|
| Professional Competence | 2 | 2008 | 66 | 0.100 |
Why?
|
| Choice Behavior | 1 | 2015 | 159 | 0.100 |
Why?
|
| Program Development | 1 | 2014 | 131 | 0.100 |
Why?
|
| Specialties, Surgical | 1 | 2014 | 75 | 0.100 |
Why?
|
| Withholding Treatment | 2 | 2019 | 121 | 0.100 |
Why?
|
| Adult | 14 | 2025 | 27918 | 0.100 |
Why?
|
| Ambulatory Care | 1 | 2014 | 193 | 0.090 |
Why?
|
| Nephrectomy | 1 | 2014 | 293 | 0.090 |
Why?
|
| Perioperative Care | 1 | 2014 | 188 | 0.090 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 220 | 0.090 |
Why?
|
| Therapeutic Equipoise | 1 | 2011 | 2 | 0.090 |
Why?
|
| Retrospective Studies | 3 | 2023 | 10164 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2014 | 298 | 0.090 |
Why?
|
| Neuroendocrine Tumors | 1 | 2014 | 136 | 0.090 |
Why?
|
| Evidence-Based Medicine | 2 | 2011 | 449 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2011 | 2441 | 0.090 |
Why?
|
| Euthanasia, Passive | 2 | 1988 | 16 | 0.090 |
Why?
|
| Aged | 8 | 2020 | 20434 | 0.090 |
Why?
|
| Health Status Indicators | 1 | 2011 | 101 | 0.080 |
Why?
|
| Liver Failure, Acute | 1 | 2011 | 38 | 0.080 |
Why?
|
| Legal Guardians | 1 | 2010 | 7 | 0.080 |
Why?
|
| Advance Directive Adherence | 1 | 2010 | 7 | 0.080 |
Why?
|
| Heart Failure | 1 | 2020 | 1386 | 0.080 |
Why?
|
| Critical Illness | 2 | 2021 | 343 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 2303 | 0.070 |
Why?
|
| Hospitals | 2 | 1988 | 328 | 0.070 |
Why?
|
| Health Care Surveys | 3 | 2020 | 285 | 0.070 |
Why?
|
| Qualitative Research | 3 | 2019 | 347 | 0.070 |
Why?
|
| Terminally Ill | 1 | 1988 | 21 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 3476 | 0.070 |
Why?
|
| Right to Die | 1 | 1988 | 12 | 0.070 |
Why?
|
| Resource Allocation | 1 | 1988 | 64 | 0.070 |
Why?
|
| Physician Executives | 1 | 2008 | 24 | 0.070 |
Why?
|
| Professional Practice | 1 | 2008 | 43 | 0.070 |
Why?
|
| Patient Participation | 2 | 2019 | 229 | 0.070 |
Why?
|
| Community-Institutional Relations | 1 | 2007 | 31 | 0.070 |
Why?
|
| Treatment Refusal | 1 | 1988 | 68 | 0.070 |
Why?
|
| Patient Admission | 1 | 2008 | 119 | 0.070 |
Why?
|
| Group Processes | 1 | 2007 | 30 | 0.060 |
Why?
|
| Value of Life | 1 | 2007 | 23 | 0.060 |
Why?
|
| American Heart Association | 1 | 2007 | 106 | 0.060 |
Why?
|
| Emergency Medicine | 1 | 2007 | 136 | 0.060 |
Why?
|
| Bariatric Surgery | 1 | 2008 | 208 | 0.060 |
Why?
|
| Obesity, Morbid | 1 | 2008 | 244 | 0.060 |
Why?
|
| Pandemics | 2 | 2023 | 873 | 0.060 |
Why?
|
| Education, Medical | 1 | 1988 | 228 | 0.060 |
Why?
|
| Interdisciplinary Communication | 2 | 2001 | 133 | 0.060 |
Why?
|
| Neoplasms | 1 | 2020 | 3169 | 0.050 |
Why?
|
| Paranasal Sinuses | 1 | 2005 | 60 | 0.050 |
Why?
|
| Anastomosis, Surgical | 1 | 2006 | 280 | 0.050 |
Why?
|
| Renal Dialysis | 1 | 1988 | 350 | 0.050 |
Why?
|
| Time Factors | 2 | 2019 | 5410 | 0.050 |
Why?
|
| Hospitalization | 1 | 2009 | 937 | 0.050 |
Why?
|
| Risk Factors | 2 | 2011 | 5899 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2007 | 429 | 0.050 |
Why?
|
| Faculty | 1 | 2023 | 36 | 0.050 |
Why?
|
| Sociology, Medical | 1 | 2002 | 6 | 0.050 |
Why?
|
| Brain Death | 1 | 2004 | 88 | 0.050 |
Why?
|
| Resuscitation Orders | 1 | 2023 | 65 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2005 | 494 | 0.050 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2003 | 156 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2004 | 236 | 0.040 |
Why?
|
| Survival Rate | 1 | 2006 | 1948 | 0.040 |
Why?
|
| Mortality | 1 | 2003 | 156 | 0.040 |
Why?
|
| Ethics Committees, Clinical | 1 | 2001 | 7 | 0.040 |
Why?
|
| Ethics, Institutional | 1 | 2001 | 8 | 0.040 |
Why?
|
| Incidence | 1 | 2006 | 1701 | 0.040 |
Why?
|
| Parents | 1 | 2004 | 292 | 0.040 |
Why?
|
| Empirical Research | 1 | 2001 | 20 | 0.040 |
Why?
|
| Standard of Care | 1 | 2022 | 70 | 0.040 |
Why?
|
| Animals | 1 | 2020 | 28155 | 0.040 |
Why?
|
| Beneficence | 1 | 2000 | 36 | 0.040 |
Why?
|
| Virtues | 1 | 2000 | 15 | 0.040 |
Why?
|
| Hospital Bed Capacity | 1 | 2020 | 20 | 0.040 |
Why?
|
| Altruism | 1 | 2000 | 33 | 0.040 |
Why?
|
| Education, Medical, Continuing | 1 | 2001 | 102 | 0.040 |
Why?
|
| Coronavirus | 1 | 2020 | 20 | 0.040 |
Why?
|
| Publishing | 1 | 2001 | 91 | 0.040 |
Why?
|
| Ownership | 1 | 2020 | 28 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2020 | 188 | 0.040 |
Why?
|
| Cardiotonic Agents | 1 | 2020 | 88 | 0.040 |
Why?
|
| Morals | 1 | 2020 | 102 | 0.040 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2020 | 92 | 0.040 |
Why?
|
| Obstetric Surgical Procedures | 1 | 2019 | 10 | 0.040 |
Why?
|
| Medicine | 1 | 2000 | 95 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2023 | 541 | 0.040 |
Why?
|
| Drug Recalls | 1 | 2019 | 12 | 0.040 |
Why?
|
| Public Health | 1 | 2020 | 153 | 0.040 |
Why?
|
| Midwestern United States | 2 | 2010 | 90 | 0.040 |
Why?
|
| Ethics | 2 | 1988 | 24 | 0.030 |
Why?
|
| Focus Groups | 1 | 2019 | 184 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2020 | 212 | 0.030 |
Why?
|
| Illinois | 1 | 2020 | 520 | 0.030 |
Why?
|
| Pharmacogenomic Testing | 1 | 2019 | 107 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2019 | 150 | 0.030 |
Why?
|
| Kidney | 1 | 2023 | 1111 | 0.030 |
Why?
|
| Organizational Policy | 2 | 1988 | 57 | 0.030 |
Why?
|
| Research | 1 | 2019 | 251 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2003 | 589 | 0.030 |
Why?
|
| Urologic Surgical Procedures | 1 | 2019 | 152 | 0.030 |
Why?
|
| Propensity Score | 1 | 2018 | 178 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 486 | 0.030 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2019 | 163 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 283 | 0.030 |
Why?
|
| Critical Care | 1 | 2020 | 444 | 0.030 |
Why?
|
| Disease Management | 1 | 2019 | 358 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2019 | 482 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2014 | 7061 | 0.030 |
Why?
|
| Adolescent | 4 | 2010 | 9606 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2003 | 754 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2008 | 9099 | 0.030 |
Why?
|
| Conscious Sedation | 1 | 2016 | 77 | 0.030 |
Why?
|
| Pediatrics | 1 | 2020 | 385 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 425 | 0.030 |
Why?
|
| Scotland | 1 | 2014 | 5 | 0.030 |
Why?
|
| Creativity | 1 | 2014 | 5 | 0.030 |
Why?
|
| History, 18th Century | 1 | 2014 | 20 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2019 | 456 | 0.030 |
Why?
|
| History, 19th Century | 1 | 2014 | 56 | 0.030 |
Why?
|
| Anesthesia | 1 | 2016 | 175 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2014 | 187 | 0.020 |
Why?
|
| Young Adult | 2 | 2020 | 6930 | 0.020 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2014 | 72 | 0.020 |
Why?
|
| Morbidity | 1 | 2013 | 162 | 0.020 |
Why?
|
| Patient Safety | 1 | 2014 | 218 | 0.020 |
Why?
|
| Risk | 1 | 2013 | 657 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 4560 | 0.020 |
Why?
|
| Living Wills | 1 | 2010 | 4 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2014 | 446 | 0.020 |
Why?
|
| Biopsy | 1 | 2014 | 1175 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 1866 | 0.020 |
Why?
|
| Social Work | 1 | 1988 | 21 | 0.020 |
Why?
|
| Clergy | 1 | 1988 | 24 | 0.020 |
Why?
|
| Bioethical Issues | 1 | 1988 | 39 | 0.020 |
Why?
|
| Biomedical Technology | 1 | 1988 | 26 | 0.020 |
Why?
|
| Nurses | 1 | 1988 | 42 | 0.020 |
Why?
|
| Civil Rights | 1 | 1988 | 8 | 0.020 |
Why?
|
| Freedom | 1 | 1988 | 19 | 0.020 |
Why?
|
| Coercion | 1 | 1988 | 16 | 0.020 |
Why?
|
| Public Policy | 1 | 1988 | 59 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 1988 | 118 | 0.020 |
Why?
|
| Life Style | 1 | 2008 | 183 | 0.020 |
Why?
|
| Social Responsibility | 1 | 2007 | 53 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 985 | 0.020 |
Why?
|
| Weight Loss | 1 | 2008 | 234 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2007 | 142 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2008 | 236 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1988 | 315 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2008 | 811 | 0.010 |
Why?
|
| Motivation | 1 | 1988 | 310 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1988 | 960 | 0.010 |
Why?
|
| Liver Regeneration | 1 | 2002 | 34 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2008 | 782 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2002 | 135 | 0.010 |
Why?
|
| Infant | 1 | 2004 | 3220 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2004 | 3829 | 0.010 |
Why?
|
| Child | 1 | 2004 | 7355 | 0.010 |
Why?
|